Get informed when a big investor buys or sells
+ Follow-3.85
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for 4732.TWO is -3.85. That is above the Healthcare sector average of -6.46. Investors often review this figure alongside NatureWise Biotech & Medicals's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, 4732.TWO currently prints -3.85 for PEG ratio, while the sector average sits near -6.46. That is roughly 40.4% above the sector mean. Large gaps often invite a closer look at NatureWise Biotech & Medicals's growth, margins, and balance sheet.
A PEG ratio of -3.85 for NatureWise Biotech & Medicals is not 'good' or 'bad' on its own. Compare it with the peer average (-6.46) and with 4732.TWO's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting 4732.TWO's PEG ratio (-3.85), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack NatureWise Biotech & Medicals's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.